Literature DB >> 8788993

Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis.

L A Magnarelli1, E Fikrig, S J Padula, J F Anderson, R A Flavell.   

Abstract

Recombinant antigens of outer surface proteins (Osps) OspA, OspB, OspC, OspE, and OspF of Borrelia burgdorferi sensu stricto and of p41-G, an antigenic region of flagellin of this spirochete, were tested with human sera in class-specific and polyvalent enzyme-linked immunosorbent assays (ELISAs). In analyses for immunoglobulin M (IgM) antibodies, 18 (85.7%) of 21 serum samples from persons who had been diagnosed as having Lyme borreliosis on the basis of the presence of erythema migrans reacted positively in ELISAs with one or more Osp antigens or the p41-G antigen. Eleven serum samples contained antibodies to OspC antigen, and of these, six also reacted to the p41-G antigen and to one or more of the other recombinant antigens. The remaining five serum samples reacted solely to OspC (n = 4) or to OspC plus OspA and OspE without reactivity to p41-G (n = 1). In analyses for IgG antibodies, seropositivity was comparable to that of IgM analyses and was marked by predominant reactivity to p41-G, OspC, and OspF. Similarly, all 21 serum samples were positive in polyvalent and class-specific ELISAs with whole-cell B. burgdorferi. Minor cross-reactivity was noted when sera from persons who had syphilis, periodontitis or other oral infections, or rheumatoid arthritis were tested with OspC, OspE, OspF, and p41-G. With relatively high degrees of specificity, ELISAs with recombinant antigens, particularly OspC and p41-G, can help to confirm B. burgdorferi infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8788993      PMCID: PMC228775          DOI: 10.1128/jcm.34.2.237-240.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Enzyme-linked immunosorbent assays for Lyme disease: reactivity of subunits of Borrelia burgdorferi.

Authors:  L A Magnarelli; J F Anderson; A G Barbour
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

2.  Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome).

Authors:  B Wilske; G Schierz; V Preac-Mursic; K von Busch; R Kühbeck; H W Pfister; K Einhäupl
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

3.  Immunoblot interpretation criteria for serodiagnosis of early Lyme disease.

Authors:  S M Engstrom; E Shoop; R C Johnson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

4.  Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi.

Authors:  L A Magnarelli; J F Anderson
Journal:  Am J Epidemiol       Date:  1988-04       Impact factor: 4.897

5.  Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease.

Authors:  L A Magnarelli; J N Miller; J F Anderson; G R Riviere
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

6.  Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.

Authors:  R J Dattwyler; D J Volkman; B J Luft; J J Halperin; J Thomas; M G Golightly
Journal:  N Engl J Med       Date:  1988-12-01       Impact factor: 91.245

Review 7.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

8.  Spirochetes in Ixodes dammini and mammals from Connecticut.

Authors:  J F Anderson; L A Magnarelli; W Burgdorfer; A G Barbour
Journal:  Am J Trop Med Hyg       Date:  1983-07       Impact factor: 2.345

9.  Cross-reactivity in serological tests for Lyme disease and other spirochetal infections.

Authors:  L A Magnarelli; J F Anderson; R C Johnson
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

10.  Immunochemical and immunological analysis of European Borrelia burgdorferi strains.

Authors:  B Wilske; V Preac-Mursic; G Schierz; K V Busch
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-12
View more
  34 in total

1.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Serodiagnosis of neuroborreliosis: comparison of reliability of three confirmatory assays.

Authors:  R Kaiser; S Rauer
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

3.  Recombinant low-molecular-mass proteins pG and LA7 from Borrelia burgdorferi reveal low diagnostic sensitivity in an enzyme-linked immunosorbent assay.

Authors:  S Rauer; R Wallich; U Neubert
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.

Authors:  Thomas B Ledue; Marilyn F Collins; John Young; Martin E Schriefer
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

5.  Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease.

Authors:  S Rauer; N Spohn; C Rasiah; U Neubert; A Vogt
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

6.  OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients.

Authors:  P Scott Hefty; Chad S Brooks; Amy M Jett; Gary L White; Stephen K Wikel; Ronald C Kennedy; Darrin R Akins
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

7.  Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A.

Authors:  Tero Heikkilä; Ilkka Seppälä; Harri Saxen; Jaana Panelius; Heta Yrjänäinen; Pekka Lahdenne
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

8.  Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.

Authors:  Gereon Goettner; Ulrike Schulte-Spechtel; Ruth Hillermann; Gabi Liegl; Bettina Wilske; Volker Fingerle
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

9.  Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.

Authors:  C A Wieneke; S D Lovrich; S M Callister; D A Jobe; J A Marks; R F Schell
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

10.  BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Authors:  Adam S Coleman; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.